Fact Checks

Publish Date
Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.

In recent months, federal policymakers have renewed calls for “Most-Favored-Nation” (MFN) drug pricing, which would tie the price of medicines in the...

Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation

Earlier this year, a coalition of technology industry lobbyists sent a letter to President Trump urging his administration to weaken protections for...

Fact Check: PERA and the PREVAIL Act Would Bolster, Not Harm, Inventors

A bipartisan group of legislators led by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE) recently reintroduced two critical bills to Congress:...

Two IP-Related Bills Would Harm U.S. Innovation, Not Help It

Congress is considering several ill-conceived bills that purport to address abuses in the patent system, but would in reality weaken core intellectual...

Fact Check: Misguided Attacks on Follow-On Patents Would Harm Patients

Critics of the U.S. patent system are increasingly targeting follow-on innovation in the biopharmaceutical sector. In an effort to weaken follow-on patents...

Fact Check: Examining Claims about China’s IP Practices

Discussions about China’s treatment of intellectual property have recently intensified in Washington, with some policymakers weighing more drastic measures to counteract perceived...

Fact Check: The U.S. Patent System Upholds High Standards of Quality

Opponents of patent rights continue to propagate the false narrative that large numbers of “bad patents” pose an existential threat to inventors...

Fact Check: PERA and the PREVAIL Act

The Patent Eligibility Restoration Act (PERA) and the Promoting and the Respecting Economically Vital American Innovation Leadership Act (PREVAIL) Act have continued...

Fact Check: Claims that Researchers Aren’t Reporting Federal Funding Don’t Hold Up to Scrutiny

Seokbeom Kwon, a systems management engineering professor at Sungkyunkwan University in South Korea, published a journal article in Science claiming that over...

Fact Check: Debunking Myths About Patents in the Pharmaceutical Industry

Activists affiliated with the Initiative for Medicines, Access & Knowledge (I-MAK) and R Street Institute have propagated false narratives about how patents...

Fact Check: The RESTORE Patent Rights Act Would Bolster America’s Innovation Economy

The RESTORE Patent Rights Act, introduced in July by a bipartisan group of senators and representatives, would be a pivotal legislative milestone...

Fact Check: The Medication Affordability and Patent Integrity Act Would Unnecessarily Overhaul a Well-Functioning Patent System

The Medication Affordability and Patent Integrity Act, introduced by Senators Maggie Hassan (D-NH) and Mike Braun (R-IN), would require life sciences innovators...

Blog:

Blog, Fact Checks:

Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.,

08/14/2025

Blog:

Blog, Fact Checks:

Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation,

07/25/2025

Blog:

Blog, Fact Checks:

Fact Check: PERA and the PREVAIL Act Would Bolster, Not Harm, Inventors,

06/18/2025

Fact Checks:

Blog, Fact Checks:

Two IP-Related Bills Would Harm U.S. Innovation, Not Help It,

05/21/2025

Blog:

Blog, Fact Checks:

Fact Check: Misguided Attacks on Follow-On Patents Would Harm Patients,

04/16/2025

Blog:

Blog, Fact Checks:

Fact Check: Examining Claims about China’s IP Practices,

03/26/2025

Blog:

Blog, Fact Checks:

Fact Check: The U.S. Patent System Upholds High Standards of Quality,

02/27/2025

Blog:

Blog, Fact Checks:

Fact Check: PERA and the PREVAIL Act,

01/09/2025

Blog:

Blog, Fact Checks:

Fact Check: Claims that Researchers Aren’t Reporting Federal Funding Don’t Hold Up to Scrutiny,

12/12/2024

Blog:

Blog, Fact Checks:

Fact Check: Debunking Myths About Patents in the Pharmaceutical Industry,

11/07/2024

Blog:

Blog, Fact Checks:

Fact Check: The RESTORE Patent Rights Act Would Bolster America’s Innovation Economy,

10/18/2024

Blog:

Blog, Fact Checks:

Fact Check: The Medication Affordability and Patent Integrity Act Would Unnecessarily Overhaul a Well-Functioning Patent System,

09/23/2024

Scroll to Top